![Mallory Morales](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mallory Morales
Comptroller/Controller/Auditor bij
IMMUNEERING CORPORATION
Vermogen: 137 390 $ op 31-08-2026
Profiel
Mallory Morales is currently Chief Accounting Officer & Senior VP-Finance at Immuneering Corp.
since 2026, with employment at the firm starting in 2021.
Former positions include Director & Assistant Controller at Immunomedics, Inc. from 2018 to 2020, Director-Finance & Global Brand Controller at L'Oréal SA from 2014 to 2018, and Partner-Strategic Finance Business at Gilead Sciences, Inc. from 2020 to 2021.
Education includes undergraduate studies at the State University of New York at Albany.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-02-2026 | 27.533 ( 0,04% ) | 137 390 $ | 31-08-2026 |
Actieve functies van Mallory Morales
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNEERING CORPORATION | Comptroller/Controller/Auditor | 10-08-2022 |
Eerdere bekende functies van Mallory Morales
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-05-2021 |
| IMMUNOMEDICS, INC. | Directeur/Bestuurslid | 01-10-2020 |
| L'ORÉAL | Financieel Directeur/CFO | 01-04-2018 |
Opleiding van Mallory Morales
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
L'Oréal SA
 L'Oréal SA Household/Personal CareConsumer Non-Durables Manufactures and markets beauty and hair products | Consumer Non-Durables |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
